HLF

$14.38+8.28%visit website

HERBALIFE LTD.

Market Cap

$1.5B

Live price × SEC shares (Oct 26, 2026)

Sector

Health Care

Industry

Wholesale-Drugs, Proprietaries & Druggists' Sundries

Beta (raw)

0.75

60mo monthly vs SPY

P/E (TTM)

8.5

TTM to Sep 2026 · diluted EPS

P/S (TTM)

0.3

TTM to Sep 2026 · revenue

P/B

N/M

TTM to Sep 2026 · negative equity

EV/EBITDA (TTM)

4.8

TTM to Sep 2026 · EV incl. net debt

Loading…

Financial Statements

USD thousands	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	Q3 FY2026 Sep 30, 2026	TTM Sep 30, 2026
Revenue	1,283,000	1,317,200	1,326,800	1,350,200	5,277,200
Cost of revenue	288,300	291,100	296,300	306,100	1,181,800
Gross profit	994,700	1,026,100	1,030,500	1,044,100	4,095,400
Operating income	99,800	138,400	128,300	138,500	505,000
Interest expense	57,800	46,800	37,400	31,900	173,900
Pretax income	50,500	91,600	(3,700)	106,600	245,000
Income tax	(34,600)	30,400	22,800	49,500	68,100
Net income	85,400	61,900	(26,300)	58,800	179,800
EPS (basic) ($)		0.60	(0.25)	0.56	1.73
EPS (diluted) ($)		0.57	(0.25)	0.55	1.70
Weighted avg. shares (basic)		103,800	104,500	105,100
Weighted avg. shares (diluted)		108,400	104,500	107,300

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Nov 2, 2026, period ended Sep 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 66 more quarters, back to Jun 2009, with Tormere Pro.

Corporate Events (8-K)

9 filings in 12 months · 1 with priority itemsFull history →

Filed	Items	Filing
Nov 2, 2026 accepted 4:22 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Aug 31, 2026 accepted 6:50 AM ET	5.02Officer / director change	Document SEC ↗
Aug 5, 2026 accepted 4:24 PM ET	2.02Earnings release5.02Officer / director change7.01Reg FD disclosure	Document SEC ↗
May 6, 2026 accepted 4:28 PM ET	2.02Earnings release5.07Shareholder vote7.01Reg FD disclosure	Document SEC ↗
May 1, 2026 accepted 4:58 PM ET	1.01Material agreement2.03New debt obligation2.04Debt acceleration8.01Other events	Document SEC ↗
Apr 16, 2026 accepted 7:32 PM ET	8.01Other events	Document SEC ↗
Apr 14, 2026 accepted 9:40 AM ET	2.02Earnings release8.01Other events	Document SEC ↗
Feb 18, 2026 accepted 4:31 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Nov 5, 2025 accepted 4:27 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Aug 6, 2025 accepted 4:26 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

56%

W/W -2.2pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-06-04	2026-06-04	L'Helias Sophie	Director	Purchase	1,200	$11.31	$14K	79.9K	View
2026-05-19	2026-05-20	Hicks Troy	Chief Operating Officer	Sale	10.0K	$12.32	$123K	9,706	View
2026-05-18	2026-05-20	Hicks Troy	Chief Operating Officer	Sale	38.4K	$12.93	$496K	9,062	View
2026-05-12	2026-05-12	Lamberti Frank	Chief Commercial Officer	Sale	135.0K	$13.50	$1.82M	36.6K	View
2026-05-11	2026-05-12	Lamberti Frank	Chief Commercial Officer	Sale	7,937	$13.86	$110K	171.6K	View